Vor Biopharma Inc.

VOR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 5, 2026
S-3ASR Sep 4, 2026 S-3ASR
4 Aug 26, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 13, 2026
10-Q Aug 11, 2026 10-Q
SCHEDULE 13G/A Aug 7, 2026
SCHEDULE 13G Aug 6, 2026
SCHEDULE 13G Jul 30, 2026
SCHEDULE 13D/A Jul 21, 2026
4 Jul 21, 2026
3 Jul 9, 2026 3
4 Jul 9, 2026 4
8-K Jul 7, 2026 8-K
4 Jun 12, 2026
4 Jun 12, 2026 4
4 Jun 12, 2026 4
4 Jun 12, 2026 4
4 Jun 12, 2026 4
4 Jun 12, 2026 4
4 Jun 12, 2026 4
4 Jun 12, 2026 4
8-K Jun 12, 2026 8-K
8-K Jun 8, 2026 8-K
← Newer Page 1 of 19 · 459 filings Older →